Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market by Application
1.3.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disease Control and Prevention Vaccine Market Perspective (2018-2029)
2.2 Global Disease Control and Prevention Vaccine Growth Trends by Region
2.2.1 Disease Control and Prevention Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Disease Control and Prevention Vaccine Historic Market Size by Region (2018-2024)
2.2.3 Disease Control and Prevention Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Disease Control and Prevention Vaccine Market Dynamics
2.3.1 Disease Control and Prevention Vaccine Industry Trends
2.3.2 Disease Control and Prevention Vaccine Market Drivers
2.3.3 Disease Control and Prevention Vaccine Market Challenges
2.3.4 Disease Control and Prevention Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Disease Control and Prevention Vaccine by Players
3.1.1 Global Disease Control and Prevention Vaccine Revenue by Players (2018-2024)
3.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2018-2024)
3.2 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Disease Control and Prevention Vaccine, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Disease Control and Prevention Vaccine Market Concentration Ratio
3.4.1 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2022
3.5 Global Key Players of Disease Control and Prevention Vaccine Head office and Area Served
3.6 Global Key Players of Disease Control and Prevention Vaccine, Product and Application
3.7 Global Key Players of Disease Control and Prevention Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Disease Control and Prevention Vaccine Breakdown Data by Type
4.1 Global Disease Control and Prevention Vaccine Historic Market Size by Type (2018-2024)
4.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029)
5 Disease Control and Prevention Vaccine Breakdown Data by Application
5.1 Global Disease Control and Prevention Vaccine Historic Market Size by Application (2018-2024)
5.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Disease Control and Prevention Vaccine Market Size (2018-2029)
6.2 North America Disease Control and Prevention Vaccine Market Size by Type
6.2.1 North America Disease Control and Prevention Vaccine Market Size by Type (2018-2024)
6.2.2 North America Disease Control and Prevention Vaccine Market Size by Type (2024-2029)
6.2.3 North America Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
6.3 North America Disease Control and Prevention Vaccine Market Size by Application
6.3.1 North America Disease Control and Prevention Vaccine Market Size by Application (2018-2024)
6.3.2 North America Disease Control and Prevention Vaccine Market Size by Application (2024-2029)
6.3.3 North America Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
6.4 North America Disease Control and Prevention Vaccine Market Size by Country
6.4.1 North America Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
6.4.3 North America Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Disease Control and Prevention Vaccine Market Size (2018-2029)
7.2 Europe Disease Control and Prevention Vaccine Market Size by Type
7.2.1 Europe Disease Control and Prevention Vaccine Market Size by Type (2018-2024)
7.2.2 Europe Disease Control and Prevention Vaccine Market Size by Type (2024-2029)
7.2.3 Europe Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
7.3 Europe Disease Control and Prevention Vaccine Market Size by Application
7.3.1 Europe Disease Control and Prevention Vaccine Market Size by Application (2018-2024)
7.3.2 Europe Disease Control and Prevention Vaccine Market Size by Application (2024-2029)
7.3.3 Europe Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
7.4 Europe Disease Control and Prevention Vaccine Market Size by Country
7.4.1 Europe Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
7.4.3 Europe Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Disease Control and Prevention Vaccine Market Size (2018-2029)
8.2 China Disease Control and Prevention Vaccine Market Size by Type
8.2.1 China Disease Control and Prevention Vaccine Market Size by Type (2018-2024)
8.2.2 China Disease Control and Prevention Vaccine Market Size by Type (2024-2029)
8.2.3 China Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
8.3 China Disease Control and Prevention Vaccine Market Size by Application
8.3.1 China Disease Control and Prevention Vaccine Market Size by Application (2018-2024)
8.3.2 China Disease Control and Prevention Vaccine Market Size by Application (2024-2029)
8.3.3 China Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Disease Control and Prevention Vaccine Market Size (2018-2029)
9.2 Asia Disease Control and Prevention Vaccine Market Size by Type
9.2.1 Asia Disease Control and Prevention Vaccine Market Size by Type (2018-2024)
9.2.2 Asia Disease Control and Prevention Vaccine Market Size by Type (2024-2029)
9.2.3 Asia Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
9.3 Asia Disease Control and Prevention Vaccine Market Size by Application
9.3.1 Asia Disease Control and Prevention Vaccine Market Size by Application (2018-2024)
9.3.2 Asia Disease Control and Prevention Vaccine Market Size by Application (2024-2029)
9.3.3 Asia Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
9.4 Asia Disease Control and Prevention Vaccine Market Size by Region
9.4.1 Asia Disease Control and Prevention Vaccine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Disease Control and Prevention Vaccine Market Size by Region (2018-2024)
9.4.3 Asia Disease Control and Prevention Vaccine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Disease Control and Prevention Vaccine Introduction
11.1.4 GSK Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.1.5 GSK Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Introduction
11.2.4 Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.2.5 Merck & Co., Inc Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Disease Control and Prevention Vaccine Introduction
11.3.4 Pfizer Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.3.5 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Disease Control and Prevention Vaccine Introduction
11.4.4 Sanofi Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.4.5 Sanofi Recent Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Details
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Introduction
11.5.4 AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.5.5 AstraZeneca PLC Recent Developments
11.6 Sinovac Biotech Ltd
11.6.1 Sinovac Biotech Ltd Company Details
11.6.2 Sinovac Biotech Ltd Business Overview
11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Introduction
11.6.4 Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.6.5 Sinovac Biotech Ltd Recent Developments
11.7 Astellas Pharma Inc
11.7.1 Astellas Pharma Inc Company Details
11.7.2 Astellas Pharma Inc Business Overview
11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Introduction
11.7.4 Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.7.5 Astellas Pharma Inc Recent Developments
11.8 Serum Institute of India Pvt. Ltd
11.8.1 Serum Institute of India Pvt. Ltd Company Details
11.8.2 Serum Institute of India Pvt. Ltd Business Overview
11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Introduction
11.8.4 Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.8.5 Serum Institute of India Pvt. Ltd Recent Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Introduction
11.9.4 Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.9.5 Daiichi Sankyo Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Disease Control and Prevention Vaccine Introduction
11.10.4 Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.10.5 Abbott Laboratories Recent Developments
11.11 Bharat Biotech International
11.11.1 Bharat Biotech International Company Details
11.11.2 Bharat Biotech International Business Overview
11.11.3 Bharat Biotech International Disease Control and Prevention Vaccine Introduction
11.11.4 Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.11.5 Bharat Biotech International Recent Developments
11.12 Bavarian Nordic A/S
11.12.1 Bavarian Nordic A/S Company Details
11.12.2 Bavarian Nordic A/S Business Overview
11.12.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Introduction
11.12.4 Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.12.5 Bavarian Nordic A/S Recent Developments
11.13 CSL Limited
11.13.1 CSL Limited Company Details
11.13.2 CSL Limited Business Overview
11.13.3 CSL Limited Disease Control and Prevention Vaccine Introduction
11.13.4 CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.13.5 CSL Limited Recent Developments
11.14 Emergent BioSolutions Inc
11.14.1 Emergent BioSolutions Inc Company Details
11.14.2 Emergent BioSolutions Inc Business Overview
11.14.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Introduction
11.14.4 Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.14.5 Emergent BioSolutions Inc Recent Developments
11.15 Inovio Pharmaceuticals Inc
11.15.1 Inovio Pharmaceuticals Inc Company Details
11.15.2 Inovio Pharmaceuticals Inc Business Overview
11.15.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Introduction
11.15.4 Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.15.5 Inovio Pharmaceuticals Inc Recent Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Details
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Disease Control and Prevention Vaccine Introduction
11.16.4 Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.16.5 Johnson & Johnson Recent Developments
11.17 Mitsubishi Tanabe Pharma Corporation
11.17.1 Mitsubishi Tanabe Pharma Corporation Company Details
11.17.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Introduction
11.17.4 Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.17.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
11.18 Novavax Inc
11.18.1 Novavax Inc Company Details
11.18.2 Novavax Inc Business Overview
11.18.3 Novavax Inc Disease Control and Prevention Vaccine Introduction
11.18.4 Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.18.5 Novavax Inc Recent Developments
11.19 Panacea Biotec Ltd
11.19.1 Panacea Biotec Ltd Company Details
11.19.2 Panacea Biotec Ltd Business Overview
11.19.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Introduction
11.19.4 Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.19.5 Panacea Biotec Ltd Recent Developments
11.20 Takeda Pharmaceutical Company Limited
11.20.1 Takeda Pharmaceutical Company Limited Company Details
11.20.2 Takeda Pharmaceutical Company Limited Business Overview
11.20.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Introduction
11.20.4 Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.20.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Live-Attenuated
Table 3. Key Players of Inactivated
Table 4. Key Players of Recombinant Sub Unit and Toxoid
Table 5. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Disease Control and Prevention Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Disease Control and Prevention Vaccine Market Share by Region (2018-2024)
Table 9. Global Disease Control and Prevention Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Disease Control and Prevention Vaccine Market Share by Region (2024-2029)
Table 11. Disease Control and Prevention Vaccine Market Trends
Table 12. Disease Control and Prevention Vaccine Market Drivers
Table 13. Disease Control and Prevention Vaccine Market Challenges
Table 14. Disease Control and Prevention Vaccine Market Restraints
Table 15. Global Disease Control and Prevention Vaccine Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Disease Control and Prevention Vaccine Revenue Share by Players (2018-2024)
Table 17. Global Top Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Table 18. Global Disease Control and Prevention Vaccine Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Disease Control and Prevention Vaccine Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Disease Control and Prevention Vaccine, Headquarters and Area Served
Table 21. Global Key Players of Disease Control and Prevention Vaccine, Product and Application
Table 22. Global Key Players of Disease Control and Prevention Vaccine, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2024)
Table 26. Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2024-2029)
Table 28. Global Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Disease Control and Prevention Vaccine Revenue Share by Application (2018-2024)
Table 30. Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Disease Control and Prevention Vaccine Revenue Share by Application (2024-2029)
Table 32. North America Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Disease Control and Prevention Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Disease Control and Prevention Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Disease Control and Prevention Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Disease Control and Prevention Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Disease Control and Prevention Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Disease Control and Prevention Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Disease Control and Prevention Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Disease Control and Prevention Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Disease Control and Prevention Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Disease Control and Prevention Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Disease Control and Prevention Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Disease Control and Prevention Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Disease Control and Prevention Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Disease Control and Prevention Vaccine Product
Table 67. GSK Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 68. GSK Recent Developments
Table 69. Merck & Co., Inc Company Details
Table 70. Merck & Co., Inc Business Overview
Table 71. Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table 72. Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 73. Merck & Co., Inc Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Disease Control and Prevention Vaccine Product
Table 77. Pfizer Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Disease Control and Prevention Vaccine Product
Table 82. Sanofi Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 83. Sanofi Recent Developments
Table 84. AstraZeneca PLC Company Details
Table 85. AstraZeneca PLC Business Overview
Table 86. AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table 87. AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 88. AstraZeneca PLC Recent Developments
Table 89. Sinovac Biotech Ltd Company Details
Table 90. Sinovac Biotech Ltd Business Overview
Table 91. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table 92. Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 93. Sinovac Biotech Ltd Recent Developments
Table 94. Astellas Pharma Inc Company Details
Table 95. Astellas Pharma Inc Business Overview
Table 96. Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table 97. Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 98. Astellas Pharma Inc Recent Developments
Table 99. Serum Institute of India Pvt. Ltd Company Details
Table 100. Serum Institute of India Pvt. Ltd Business Overview
Table 101. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table 102. Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 103. Serum Institute of India Pvt. Ltd Recent Developments
Table 104. Daiichi Sankyo Company Details
Table 105. Daiichi Sankyo Business Overview
Table 106. Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table 107. Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 108. Daiichi Sankyo Recent Developments
Table 109. Abbott Laboratories Company Details
Table 110. Abbott Laboratories Business Overview
Table 111. Abbott Laboratories Disease Control and Prevention Vaccine Product
Table 112. Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 113. Abbott Laboratories Recent Developments
Table 114. Bharat Biotech International Company Details
Table 115. Bharat Biotech International Business Overview
Table 116. Bharat Biotech International Disease Control and Prevention Vaccine Product
Table 117. Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 118. Bharat Biotech International Recent Developments
Table 119. Bavarian Nordic A/S Company Details
Table 120. Bavarian Nordic A/S Business Overview
Table 121. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product
Table 122. Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 123. Bavarian Nordic A/S Recent Developments
Table 124. CSL Limited Company Details
Table 125. CSL Limited Business Overview
Table 126. CSL Limited Disease Control and Prevention Vaccine Product
Table 127. CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 128. CSL Limited Recent Developments
Table 129. Emergent BioSolutions Inc Company Details
Table 130. Emergent BioSolutions Inc Business Overview
Table 131. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product
Table 132. Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 133. Emergent BioSolutions Inc Recent Developments
Table 134. Inovio Pharmaceuticals Inc Company Details
Table 135. Inovio Pharmaceuticals Inc Business Overview
Table 136. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product
Table 137. Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 138. Inovio Pharmaceuticals Inc Recent Developments
Table 139. Johnson & Johnson Company Details
Table 140. Johnson & Johnson Business Overview
Table 141. Johnson & Johnson Disease Control and Prevention Vaccine Product
Table 142. Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 143. Johnson & Johnson Recent Developments
Table 144. Mitsubishi Tanabe Pharma Corporation Company Details
Table 145. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 146. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product
Table 147. Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 148. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 149. Novavax Inc Company Details
Table 150. Novavax Inc Business Overview
Table 151. Novavax Inc Disease Control and Prevention Vaccine Product
Table 152. Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 153. Novavax Inc Recent Developments
Table 154. Panacea Biotec Ltd Company Details
Table 155. Panacea Biotec Ltd Business Overview
Table 156. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product
Table 157. Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 158. Panacea Biotec Ltd Recent Developments
Table 159. Takeda Pharmaceutical Company Limited Company Details
Table 160. Takeda Pharmaceutical Company Limited Business Overview
Table 161. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product
Table 162. Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 163. Takeda Pharmaceutical Company Limited Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Disease Control and Prevention Vaccine Market Share by Type: 2022 VS 2029
Figure 3. Live-Attenuated Features
Figure 4. Inactivated Features
Figure 5. Recombinant Sub Unit and Toxoid Features
Figure 6. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Disease Control and Prevention Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Pediatric Vaccine Case Studies
Figure 9. Adult Vaccine Case Studies
Figure 10. Disease Control and Prevention Vaccine Report Years Considered
Figure 11. Global Disease Control and Prevention Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Disease Control and Prevention Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Disease Control and Prevention Vaccine Market Share by Region: 2022 VS 2029
Figure 14. Global Disease Control and Prevention Vaccine Market Share by Players in 2022
Figure 15. Global Top Disease Control and Prevention Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Disease Control and Prevention Vaccine Revenue in 2022
Figure 17. North America Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
Figure 19. North America Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
Figure 20. North America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 21. United States Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Disease Control and Prevention Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
Figure 25. Europe Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
Figure 26. Europe Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 27. Germany Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Disease Control and Prevention Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
Figure 35. China Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
Figure 36. Asia Disease Control and Prevention Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
Figure 38. Asia Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
Figure 39. Asia Disease Control and Prevention Vaccine Market Share by Region (2018-2029)
Figure 40. Japan Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 50. Brazil Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 57. Merck & Co., Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 58. Pfizer Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 59. Sanofi Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 60. AstraZeneca PLC Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 61. Sinovac Biotech Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 62. Astellas Pharma Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 63. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 65. Abbott Laboratories Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 66. Bharat Biotech International Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 67. Bavarian Nordic A/S Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 68. CSL Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 69. Emergent BioSolutions Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 70. Inovio Pharmaceuticals Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 71. Johnson & Johnson Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 72. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 73. Novavax Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 74. Panacea Biotec Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 75. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed